Insider · CIK 0002052802
John J. Abularrage
Files at BGC (BGC Group, Inc.). First filing -, latest -.
In brief
John J. Abularrage files SEC Form 4 as CEO at BGC (BGC Group, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; John J. Abularrage has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | BGC BGC Group, Inc. | AGrant or award Class A Common Stock, par value $0.01 per share | +350,727 | - | - | 832,072 | Apr 1, 2026 |
| Apr 1, 2025 | BGC BGC Group, Inc. | AGrant or award Class A Common Stock, par value $0.01 per share | +164,890 | - | - | 522,861 | Mar 16, 2026 |
| Mar 15, 2026 | BGC BGC Group, Inc. | FTax withholding Class A Common Stock, par value $0.01 per share | -41,516 | $9.57 | $397k | 481,345 | Mar 16, 2026 |
Questions about John J. Abularrage
Answered from the filings on this page, as of the latest one.
Is John J. Abularrage buying or selling?
John J. Abularrage has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did John J. Abularrage's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John J. Abularrage has 0.
Where does John J. Abularrage file Form 4?
John J. Abularrage has filed Form 4 at BGC (BGC Group, Inc.) as Co-Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.